PharmaResources (Shanghai) Co., Ltd.

SZSE:301230 Stock Report

Market Cap: CN¥3.4b

PharmaResources (Shanghai) Balance Sheet Health

Financial Health criteria checks 4/6

PharmaResources (Shanghai) has a total shareholder equity of CN¥1.0B and total debt of CN¥12.3M, which brings its debt-to-equity ratio to 1.2%. Its total assets and total liabilities are CN¥1.4B and CN¥313.6M respectively.

Key information

1.2%

Debt to equity ratio

CN¥12.33m

Debt

Interest coverage ration/a
CashCN¥363.03m
EquityCN¥1.04b
Total liabilitiesCN¥313.61m
Total assetsCN¥1.36b

Recent financial health updates

No updates

Recent updates

PharmaResources (Shanghai) Co., Ltd.'s (SZSE:301230) P/S Is Still On The Mark Following 39% Share Price Bounce

Oct 10
PharmaResources (Shanghai) Co., Ltd.'s (SZSE:301230) P/S Is Still On The Mark Following 39% Share Price Bounce

PharmaResources (Shanghai) (SZSE:301230) Posted Weak Earnings But There Is More To Worry About

May 02
PharmaResources (Shanghai) (SZSE:301230) Posted Weak Earnings But There Is More To Worry About

Financial Position Analysis

Short Term Liabilities: 301230's short term assets (CN¥620.5M) exceed its short term liabilities (CN¥150.7M).

Long Term Liabilities: 301230's short term assets (CN¥620.5M) exceed its long term liabilities (CN¥163.0M).


Debt to Equity History and Analysis

Debt Level: 301230 has more cash than its total debt.

Reducing Debt: 301230's debt to equity ratio has reduced from 10.7% to 1.2% over the past 5 years.

Debt Coverage: 301230's operating cash flow is negative, therefore debt is not well covered.

Interest Coverage: Insufficient data to determine if 301230's interest payments on its debt are well covered by EBIT.


Balance Sheet


Discover healthy companies